We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Impedance Scanning for Breast Cancer

By HospiMedica staff writers
Posted on 13 Jun 2005
A painless, portable device that uses electrical current instead of x-rays to examine breast for tumors is currently being evaluated at 20 centers worldwide.

Impedance scanning is a method based on evidence that an electrical current passes through cancerous tissue more easily than it does with healthy tissue. More...
Earlier studies have demonstrated that the technique, which takes approximately 10 minutes and does not require frequently uncomfortable breast compression, can identify extremely small tumors, according to its developers, Z-Tech, Inc. (Charleston, SC, USA).

The study was comprised of about 4,500 women, and will determine whether the device, which generates a report instead of a breast image, is accurate enough for widespread use, according to Dr. James H. Craft, chief investigator of the study and a radiologist at the Medical College of Georgia (Augusta, GA), one of the centers in which the device is currently being evaluated.

Impedance scanning involves positioning a flower-shaped grouping of electrodes with a hole in the center for the nipple over each breast. A small amount of electricity is delivered through the breast and a computer immediately calculates and produces findings based on benchmarks for negative and positive results. Rather than waiting for a radiologist for examine a mammogram, the computer immediately notes whether the image is homologous electrical difference analysis- (HEDA)-negative, meaning no cancer was detected, or positive.

It has been known for quite a while that when a tumor occurs in the breast, the impedance of electricity through that site is decreased, according to Dr. Craft. Seemingly, cell permeability increases so water flows through the cells more than in normal tissue. The electrical signature of that tissue is different. Electrocardiographs, which have been utilized for years to evaluate heart muscle, are also based on the hypothesis that healthy and diseased tissue conduct electricity differently.

HEDA does not utilize radiation so it does not require lead-lined scan rooms, and is very portable, which enhances its user-friendliness in even the most remote regions of the world, according to Dr. Craft. It could be put in a van with a generator and could travel to screen a large number of women. HEDA may someday surpass mammography screening accuracy, especially in evaluating the dense breasts of younger women. Less-dense breasts appear darker in a mammography, making them easier for the radiologists to evaluate. Feasibly, if this study could be applied to younger women in the near future, tumors in women who are in their 20s can be more readily detected and thus save many lives inexpensively and without the radiation risk.

Exclusionary factors for HEDA include earlier breast surgery, anatomic abnormalities, nipple rings, and women who are breast feeding or pregnant. Possible side effects include localized irritation at the electrode site, an infrequent occurrence that usually resolves within 24 hours.





Related Links:
Z-Tech
Medical College of Georgia

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.